Completed PHASE3 INTERVENTIONAL NCT00002898

Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma

MMT 95 Study For Rhabdomyosarcoma and Other Malignant Soft Tissue Tumors of Childhood

Sponsor: Societe Internationale d'Oncologie Pediatrique

Conditions Childhood Malignant Fibrous Histiocytoma of Bone Sarcoma

Interventions adjuvant therapy brachytherapy carboplatin conventional surgery cyclophosphamide dactinomycin epirubicin hydrochloride etoposide ifosfamide neoadjuvant therapy radiation therapy vincristine sulfate

Updated 5 times since 2017 Last updated: Dec 3, 2013 Started: Jan 31, 1995 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Childhood Malignant Fibrous Histiocytoma of Bone and Sarcoma and is currently completed. Societe Internationale d'Oncologie Pediatrique leads this study, which shows 5 recorded versions since 1995 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 1995

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Societe Internationale d'Oncologie Pediatrique

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bristol, United Kingdom